A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1/TGF-Β pathway
Naunyn-Schmiedeberg's Archives of Pharmacology · 2024-09 · 397 (9) · 6919-6927
DOI: 10.1007/s00210-024-03052-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 09.04.2024. Verfasst von Heba M Karam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Drug Radiation Research Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt. heba.karam…. Hauptthemen laut MEDLINE: Fibrosis, Metformin, Chemokine CXCL1, Nanoparticles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Egyptian Atomic Energy Authority.
Abstract (Originalsprache)
The present work investigates the potential role of metformin nanoparticles (MTF-NPs) as a radio-protector against cardiac fibrosis and inflammation induced by gamma radiation via CXCL1/TGF-β pathway. Lethal dose fifty of nano-metformin was determined in mice, then 21 rats (male albino) were equally divided into three groups: normal control (G1), irradiated control (G2), and MTF-NPs + IRR (G3). The possible protective effect of MTF-NPs is illustrated via decreasing cardiac contents of troponin, C-X-C motif Ligand 1 (CXCL1), tumor growth factor β (TGF-β), protein kinase B (AKT), and nuclear factor-κB (NF-κB). Also, the positive effect of MTF-NPs on insulin-like growth factor (IGF) and platelet-derived growth factor (PDGF) in heart tissues using immunohistochemical technique is illustrated in the present study. Histopathological examination emphasizes the biochemical findings. The current investigation suggests that MTF-NPs might be considered as a potent novel treatment for the management of cardiac fibrosis and inflammation in patients who receive radiotherapy or workers who may be exposed to gamma radiation. Graphical Abstract
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Drug Radiation Research Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt. heba.karam.mohmed@gmail.com.
- Drug Radiation Research Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt.
- Department of Chemistry and Chemical Biology, McMaster University, 1280 Main Street West, Hamilton, ON, L8S4L8, Canada.
- Drug Radiation Research Department, National Center for Radiation Research and Technology, Egyptian Atomic Energy Authority, Cairo, Egypt. farag.abomosalam@eaea.org.eg.
- Anatomic Pathology Department, Faculty of Veterinary medicine, Cairo University, Cairo, Egypt.
Förderung
- Egyptian Atomic Energy Authority
Zitieren
APA
Karam, H. M., Lotfy, D. M., A Ibrahim, A., Mosallam, F. M., Abdelrahman, S. S., & Abd-ElRaouf, A. (2024). A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1/TGF-Β pathway. Naunyn-Schmiedeberg's Archives of Pharmacology, 397(9), 6919-6927. https://doi.org/10.1007/s00210-024-03052-4
Vancouver
Karam HM, Lotfy DM, A Ibrahim A, Mosallam FM, Abdelrahman SS, Abd-ElRaouf A. A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1/TGF-Β pathway. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024;397(9):6919-6927. doi:10.1007/s00210-024-03052-4
BibTeX
@article{Karam2024,
author = {Karam, Heba M and Lotfy, Dina M and A Ibrahim, Ayman and Mosallam, Farag M and Abdelrahman, Sahar S and Abd-ElRaouf, Amira},
title = {A new approach of nano-metformin as a protector against radiation-induced cardiac fibrosis and inflammation via CXCL1/TGF-Β pathway},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2024},
volume = {397},
number = {9},
pages = {6919--6927},
doi = {10.1007/s00210-024-03052-4}
}
EUVIMED